Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
| ▸ | CCR2 | P41597 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4170126 | 0.95 | CYP1A2 (0.42) | CYP1A2PKMMEN1KMT2AHTT | |
| SCHEMBL504003 | 0.95 | CYP1A2 (0.41) | CYP1A2PKMMEN1KMT2AHTT | |
| SCHEMBL5862504 | 0.93 | HTT (0.40) | CYP1A2PKMMEN1KMT2AHTT | |
| SCHEMBL1896640 | 0.93 | HTT (0.40) | CYP1A2PKMMEN1KMT2AHTT | |
| SCHEMBL11290481 | 0.93 | HTT (0.40) | CYP1A2PKMMEN1KMT2AHTT | |
| SCHEMBL8975284 | 0.93 | HTT (0.40) | CYP1A2PKMMEN1KMT2AHTT | |
| SCHEMBL1893345 | 0.90 | CYP1A2 (0.47) | CYP1A2PKMMEN1KMT2AHTT | |
| SCHEMBL4159287 | 0.88 | TLR4 (0.35) | CYP2C9HPGD | |
| SCHEMBL8735525 | 0.88 | CYP1A2 (0.36) | CYP1A2PKMMEN1KMT2AHTT | |
| SCHEMBL7723142 | 0.87 | CYP1A2 (0.35) | CYP1A2PKMMEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2566934-B1 | LIQUID CRYSTALLINE MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2016-12-07 | — | — | EP | disclosed |
| EP-3093328-A1 | LIQUID CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2016-11-16 | — | — | EP | disclosed |
| EP-2630217-B1 | SWITCH ELEMENT COMPRISING A LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2016-10-26 | — | — | EP | disclosed |
| EP-2985334-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2016-02-17 | — | — | EP | disclosed |
| EP-2649153-B1 | LIQUID CRYSTAL MEDIUM AND ELECTROOPTIC DISPLAY | MERCK PATENT GMBH (DE) | 2014-12-17 | — | — | EP | disclosed |
| EP-2652088-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2014-10-15 | — | — | EP | disclosed |
| EP-2722380-A2 | Liquid crystal medium, method for the stabilisation thereof and liquid crystal display | Merck Patent GmbH (DE) | 2014-04-23 | — | — | EP | disclosed |
| WO-2013124040-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2013-08-29 | — | — | WO | disclosed |
| US-8293146-B2 | Optical film and phase difference plate, and liquid crystal compound | FUJIFILM CORPORATION (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20090159857-A1 | OPTICAL FILM AND PHASE DIFFERENCE PLATE, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2009-06-25 | — | — | US | disclosed |
| WO-2007091716-A1 | OPTICAL FILM AND PHASE DIFFERENCE PLATE, AND LIQUID CRYSTAL COMPOUND | FUJIFILM CORPORATION (JP) | 2007-08-16 | — | — | WO | disclosed |
| US-4323504-A | Cyclohexyl cyclohexyl dioxane liquid crystalline compounds and admixture containing same | TIMEX CORPORATION (US) | 1982-04-06 | — | — | US | disclosed |
| US-4323473-A | Cyclohexyl cyclohexyl dioxane liquid crystalline compounds and admixture containing same | TIMEX CORPORATION (US) | 1982-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090159857-A1 | OPTICAL FILM AND PHASE DIFFERENCE PLATE, AND LIQUID CRYSTAL COMPOUND | NOM1, CRYZ, CNN2 | CYP1A2 3757/4885PKM 4809/4885MEN1 1129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.